LATE–a novel sensitive cell-based assay for the study of CRISPR/Cas9-related long-term adverse treatment effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LATE–a novel sensitive cell-based assay for the study of CRISPR/Cas9-related long-term adverse treatment effects

Published:2021-09 Issue: Volume:22 Page:249-262
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Głów Dawid,Meyer Simon,García Roldán Irene,Akingunsade Lara Marie,Riecken Kristoffer,Fehse Boris

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference54 articles.

1. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli;Sapranauskas;Nucleic Acids Res.,2011

2. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity;Jinek;Science,2012

3. Multiplex genome engineering using CRISPR/Cas systems;Cong;Science,2013

4. RNA-guided human genome engineering via Cas9;Mali;Science,2013

5. RNA-programmed genome editing in human cells;Jinek;eLife,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article;Human Gene Therapy;2024-08-01

2. Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies;AAPS PharmSciTech;2024-06-06

3. Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies;Mutation Research - Genetic Toxicology and Environmental Mutagenesis;2024-05

4. Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPs;International Journal of Molecular Sciences;2023-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3